Search

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

4.5 (219) · $ 13.50 · In stock

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY
Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

Navigating the emerging complexities of melanoma treatment: New insights  for clinical practice - touchONCOLOGY

Navigating the emerging complexities of melanoma treatment: New insights for clinical practice - touchONCOLOGY

Personalized treatment of RET-altered thyroid cancers: What is the value of  biomarker testing and targeted therapies? – touchENDOCRINOLOGY

Personalized treatment of RET-altered thyroid cancers: What is the value of biomarker testing and targeted therapies? – touchENDOCRINOLOGY

Molecular cancer screening: in search of evidence

Molecular cancer screening: in search of evidence

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in  Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Advances in the Treatment of Systemic Sclerosis - touchIMMUNOLOGY

Advances in the Treatment of Systemic Sclerosis - touchIMMUNOLOGY

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

touchRESPIRATORY - Online Education for Pulmonologists

touchRESPIRATORY - Online Education for Pulmonologists

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

CME - touchONCOLOGY

CME - touchONCOLOGY